The Society for Cardiovascular Angiography and Interventions (SCAI) weighed in on the ongoing debate regarding the long-term safety of paclitaxel-coated balloons and stents on Jan. 25, largely agreeing with the FDA’s stance that the benefits of such devices appear to outweigh the risks until more information becomes available.

The risk of infective endocarditis rises alongside concomitant use of injected opioids, a team of researchers in Ontario, Canada, has found.

Jeffrey S. Klein, MD, will be stepping down as editor of the Radiological Society of North America (RSNA)’s journal RadioGraphics. In the wake of the announcement, the journal is now looking for a new editor.

Tencent, a Chinese multinational investment holding conglomerate, and Merck KGaA, a German-based pharmaceutical, life sciences and technology company, are collaborating to increase disease awareness and provide more accessible healthcare services via digital platforms in China by leveraging AI and big data.

A Seattle-based startup, 98point6, is looking to become the Amazon of primary care, according to a profile by CNBC.

A pair of specialists recently took on the topic of the word "cancer" in a Jan. 23 viewpoint published in The BMJ, arguing that changing the terminology could ease patient anxiety or create more fear.

Accuray Asia Limited, a subsidiary of Sunnyvale, California-based Accuray, has entered into a joint venture with CNNC High Energy Equipment, a subsidiary of Tianjin, China-based China Isotope and Radiation Corporation (CIRC), to sell radiation oncology systems throughout China. 

The use of transcatheter mitral valve repair (TMVR) systems continues to grow rapidly nearly six years after the FDA approved the U.S.'s first such treatment, according to research published in the American Journal of Cardiology. In contrast, rates of surgical mitral valve repair (SMVR) have remained steady.

The implementation of digital breast tomosynthesis (DBT) at eight radiology facilities in Vermont led to lower recall rates than full-field digital mammography (FFDM) alone, according to a new study published in the American Journal of Roentgenology. However, the authors observed no improvements in cancer detection rates.

Five major pharmaceutical companies could each lose $500 million or more in revenue per year if a proposal from the Trump administration to reimburse Medicare Part B drugs based on an international pricing index (IPI) is finalized.